Drug immunoassays.
D000700:Analgesics / Q000032:analysis; D000818:Animals; D000900:Anti-Bacterial Agents / Q000032:analysis; D000917:Antibody Formation; D000918:Antibody Specificity; D000927:Anticonvulsants / Q000032:analysis; D002301:Cardiac Glycosides / Q000032:analysis; D002352:Carrier Proteins; D003168:Complement Fixation Tests; D004334:Drug Administration Schedule; D004341:Drug Evaluation / Q000379:methods*; D006168:Guinea Pigs / Q000276:immunology; D006241:Haptens; D006385:Hemagglutination Inhibition Tests; D006993:Hypnotics and Sedatives / Q000032:analysis; D007106:Immune Sera; D007114:Immunization; D007118:Immunoassay; D009022:Morphine Derivatives / Q000032:analysis; D011817:Rabbits / Q000276:immunology; D011868:Radioisotopes; D012709:Serum Albumin; D013256:Steroids / Q000032:analysis
D000700:Analgesics; D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D002301:Cardiac Glycosides; D002352:Carrier Proteins; D006241:Haptens; D006993:Hypnotics and Sedatives; D007106:Immune Sera; D009022:Morphine Derivatives; D011868:Radioisotopes; D012709:Serum Albumin; D013256:Steroids